ODI PHARMA AB (F:6OD) — Stock Price

€0.13 EUR
▼ -2.99% today

ODI PHARMA AB (F:6OD) is currently trading at €0.13 EUR, down 2.99% today. Over the past 52 weeks, shares have ranged between €0.06 and €0.40. This page tracks ODI PHARMA AB's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see ODI PHARMA AB cash conversion from operations.

ODI PHARMA AB (6OD) Stock Price Chart — Daily History & Trading Volume

The chart below tracks ODI PHARMA AB's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.

ODI PHARMA AB Income Statement — Revenue, Profit & Earnings by Year

ODI PHARMA AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue €32.92 Million €3.13 Million €22.29 Million €139.46K €312.94K
Cost of Revenue €22.65 Million €2.29 Million €17.66 Million €857.82K €416.57K
Gross Profit €10.27 Million €839.06K €4.62 Million €-718.36K €-103.64K
Research & Development — — — — —
SG&A — — — — —
Total Operating Expenses €30.41 Million €8.59 Million €21.86 Million €6.95 Million €7.52 Million
Operating Income €2.50 Million €-5.45 Million €428.09K €-6.81 Million €-7.21 Million
EBITDA — — — — —
EBIT — — — — —
Interest Expense €602.88K €741.01K €855.02K €107.67K €28.76K
Income Before Tax €1.99 Million €-5.93 Million €-379.47K €-6.90 Million €-7.24 Million
Income Tax Expense — — — — —
Net Income €1.99 Million €-5.93 Million €-568.06K €-6.90 Million €-7.24 Million

ODI PHARMA AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes ODI PHARMA AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets €5.30 Million €4.61 Million €12.23 Million €8.19 Million €10.50 Million
Total Current Assets €5.29 Million €3.61 Million €12.22 Million €8.18 Million €10.48 Million
Cash & Equivalents — — — — —
Short-term Investments — — — — —
Net Receivables €180.64K €115.58K €8.07 Million €132.61K €108.63K
Inventory €0.00 €0.00 €0.00 €807.94K €1.55 Million
Property, Plant & Equipment — — — — —
Goodwill — — — — —
Total Liabilities €2.93 Million €4.19 Million €10.23 Million €5.61 Million €1.24 Million
Total Current Liabilities €2.93 Million €4.19 Million €10.23 Million €5.61 Million €1.24 Million
Long-term Debt — — — — —
Net Debt — — — — —
Total Stockholder Equity €2.38 Million €424.64K €2.00 Million €2.57 Million €9.26 Million
Retained Earnings — — — — —

ODI PHARMA AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how ODI PHARMA AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow €4.58 Million €-3.31 Million €-3.82 Million €-5.10 Million €-7.37 Million
Capital Expenditures €0.00 €0.00 €0.00 €0.00 €4.11K
Free Cash Flow €4.58 Million €-3.31 Million €-3.82 Million €-5.10 Million €-7.38 Million
Investing Cash Flow — — — — —
Financing Cash Flow — — — — —
Dividends Paid — — — — —
Stock-Based Compensation — — — — —
Depreciation €4.65K €1.96K €3.10K €4.11K €5.59K
Change in Cash €1.79 Million €-1.07 Million €-3.82 Million €-1.04 Million €-7.38 Million

ODI PHARMA AB Earnings History — EPS Actual vs. Analyst Estimates

Track ODI PHARMA AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Earnings history is not currently available for ODI PHARMA AB.